A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/337 (2006.01) A61K 31/351 (2006.01) A61K 31/66 (2006.01) A61K 31/704 (2006.01) A61P 35/04 (2006.01)
Patent
CA 2486124
The present invention relates to a new method of adjuvant therapy in the treatment of metastatic breast or ovarian cancer, comprising administering six cycles of docetaxel, doxorubicin and cyclophosphamide to a patient in need thereof, wherein said dosages have a marked therapeutic effect when compared to other adjuvant therapies.
La présente invention concerne une nouvelle méthode de thérapie adjuvante utilisée dans le traitement du cancer du sein ou de l'ovaire métastatique, consistant à administrer six cycles de docetaxel, de doxorubicine et de cyclophosphamide à un patient en ayant besoin, lesdits dosages présentant un effet thérapeutique certain par rapport à d'autres thérapies adjuvantes.
Chakroun Hichem
Aventis Pharma S.a.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1476389